Subjects - Finance

Over recent years personal debt in the UK has exploded. Since 1997 the total debt including mortgages was in the region of ?940 million. Approxi

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

mately 18% of that figure is unsecured credit, accounting for about ?8000 per household.

This is a staggering amount of money. With interest ra

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

es being raised several times last year, the strain of maintaining our debt is taking its toll. Sources reveal that the UK’s debt “has increased

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

every single month without fail since April 1993”.

As it has been relatively cheap to borrow money over that last few years it has been very ea

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

y to get access to money. Interest rates are widely predicted to rise further adding even more to the current ?5 billion we are paying every mo

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

th in interest.

According to the FSA (Financial Services Authority) one pound in every 10 we spend is borrowed money. It’s very easy to shop ar

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

und for good rates when borrowing money. Most of us still buy our financial products on the high street and the big Financial Institutions base

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

the price of their products on what they think is the maximum borrowers are prepared to pay.

With the internet people are able to shop around f

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

r much better rates and this is driving the average price of borrowing money down. This does pose a catch 22 situation as the cheaper the cost o

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

borrowing becomes the more people will feel they can borrow more. This does breed a nation of people that are living beyond their means. Debt c

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

n be very dangerous as you are effectively borrowing from your future to pay for today.

The wage rate is not growing in line with rising debts

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

o somewhere along the line something has got to give. This may be in the form of the slightest interest rate rise which may be the straw on the

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

roverbial camels back. One could associate it with a brick that is attached to an elastic band. You can gently pull and pull and nothing will ha

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

pen, sooner or later the brick will finally budge and most of use will be walking around with a black eye.

If you do find yourself in debt then

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

don’t despair it’s not the end of the world. As long as you face up to the fact that your financial position needs a makeover then you are on t

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

e right path. The first thing to is gather all you credit statements and get an exact figure of what you owe in total and what those monthly pay

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ents add up to. You need to be clear in your mind what you earn and what you owe. This sounds simple but you can’t service your credit if your r

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

payments are more than what you earn. If you find yourself in this position you need to consolidate all your loans into the lowest rate you can

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ind. This will bring down you monthly payments and hopefully be more manageable.

If you need help on doing this then contact the National Debtl

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ne on (Freephone) 0808 808 4000 or the Consumer Credit Counselling Service on (Freephone) 0800 138 1111. These numbers are for UK residents only

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/99369/subjects-The-Burden-of-Debt.html">The Burden of Debt</a>

BB link (for phorums):
[url=http://www.subjects.org.ua/article/99369/subjects-The-Burden-of-Debt.html]The Burden of Debt[/url]

This article provides an introduction to financial accounting, its purpose, the four basic financial statements, and the concept of generally accepted accounting principles (GAAP) which is used to prepare these financial statements.

Education is a fundamental of any industrialized nation, and so it is natural that qualified teachers remain in demand throughout the world. In the U.S., there were over 3.8 million teaching jobs for 2004 including preschool, kindergarten, elementary, middle school, and secondary school teachers. If you are seeking a career that will see good growth and with high employment availability, then becoming qualified for teaching jobs may be a proper career choice for you.

Tags

Links

Subjects - The Burden of Debt

Related Articles: